Medicaid Managed Care Prior Authorization For Buprenorphine Tied To State Partisanship And Health Plan Profit Status, 2018
- 1 January 2024
- journal article
- research article
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 43 (1) , 55-63
Abstract
Buprenorphine is among the most effective drugs for treating opioid use disorder, yet only a quarter of Americans who need it receive it. Requiring prior authorization has been identified as an important barrier to buprenorphine access. However, the practice remains widespread in Medicaid-the largest insurer of Americans with opioid use disorder. In this study, we examined how prior authorization for buprenorphine is related to plan structure and state political environment, using data on all 266 comprehensive Medicaid managed care plans active in 2018. We found substantial variation in prior authorization use across states, with all plans requiring prior authorization in eleven states and no plans requiring it in thirteen other states. We found that for-profit plans and those located in Republican states were more likely to impose prior authorization policies. Our findings suggest that managed care plans' decisions regarding use of prior authorization may be shaped by internal pressures to control costs, as well as by differing partisan stances regarding the need to prevent criminal diversion of buprenorphine.Keywords
This publication has 19 references indexed in Scilit:
- Demystifying Buprenorphine Misuse: Has Fear of Diversion Gotten in the Way of Addressing the Opioid Crisis?Substance Abuse, 2019
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With MortalityAnnals of Internal Medicine, 2018
- The Politics of Medicaid: Most Americans Are Connected to the Program, Support Its Expansion, and Do Not View It as StigmatizingThe Milbank Quarterly, 2017
- Buprenorphine prescribing practice trends and attitudes among New York providersJournal of Substance Abuse Treatment, 2017
- Spending On Mental And Substance Use Disorders Projected To Grow More Slowly Than All Health Spending Through 2020Health Affairs, 2014
- Drug policy and the public good: evidence for effective interventionsThe Lancet, 2012
- Do For-Profit Health Plans Restrict Access to Care Under Medicaid Managed Care?Medical Care Research and Review, 2008
- The Extent of the Market and the Supply of RegulationThe Quarterly Journal of Economics, 2005
- National Committee on Quality Assurance Health-Plan AccreditationMedical Care, 2002
- Health Plan Characteristics And Consumers’ Assessments Of QualityHealth Affairs, 2001